Tissue factor-factor VIIa signaling

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 1, 2005, Pages 47-56

  Rao, L Vijaya Mohan ^a   Pendurthi, Usha R ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Cell signaling; Factor VIIa; Protease activated receptors; Tissue factor

Indexed keywords

BLOOD CLOTTING FACTOR 7A; G PROTEIN COUPLED RECEPTOR; PROTEINASE ACTIVATED RECEPTOR; THROMBOPLASTIN;

ANIMAL CELL; BLOOD CLOTTING; CELL FUNCTION; CYTOPLASM; IN VIVO STUDY; MODEL; NONHUMAN; PATHOPHYSIOLOGY; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; FACTOR VIIA; HUMANS; SIGNAL TRANSDUCTION; THROMBOPLASTIN;

EID: 11144231364     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000151624.45775.13     Document Type: Short Survey

References (120)

1. Fleck RA, Rao LVM, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;59:421-437.
2. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: Implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134:1087-1097.
3. Osterud B. Tissue factor expression by monocytes: regulation and pathophysiological role. Blood Coag Fibrinol. 1998;9:S9-S14.
4. Contrino J, Hair G, Kreutzer DL, Rickles FR. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease. Nat Med. 1996;2:209-215.
5. Luther T, Flossel C, Albrecht S, Kotzsch M, Muller M. Tissue factor expression in normal and abnormal mammary gland. Nat Med. 1996;2:491-492.
6. McNamara CA, Sarenbock IJ, Gimple LW, Fenton II JW, Coughlin SR, Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest. 1993;91:94-98.
7. Gasic GP, Arenas CP, Gasic TB, Gasic GJ. Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells. Proc Natl Acad Sci USA. 1992;89:2317-2320.
8. Coughlin SR. Protease-activated receptors in vascular biology. Thromb Haemost. 2001;86:298-307.
9. Pendurthi UR, Rao LVM. Factor VIIa/tissue factor-induced signaling: A link between clotting and disease. In: Litwick G, ed. Vitamins and Hormones. San Diego: Academic Press; 2002:323-355.
10. Ruf W, Mueller BM. Tissue factor in cancer angiogenesis and metastasis. Curr Opin Hematol. 1996;3:379-384.
11. Mackman N. Role of tissue factor in hemostasis, thrombosis, and vascular development. Arterioscler Thromb Vasc Biol. 2004;24:1015-1022.
12. Riewald M, Kravchenko VV, Petrovan R, O'brien PJ, Brass LF, Ulevitch RJ, Ruf W. Gene induction by coagulation factor Xa is mediated by activation of PAR-1. Blood. 2001;97:3109-3116.
13. Riewald M, Petrovan RJ, Donner A, Ruf W. Activated protein C signals through the thrombin receptor PAR1 in endothelial cells. J Endotoxin Res. 2003;9:317-321.
14. Pendurthi UR, Ngyuen M, Andrade-Gordon P, Petersen LC, Rao LVM. Plasmin induces Cyr61 gene expression in fibroblasts via protease activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway. Arterioscler Thromb Vasc Biol. 2002;22:1421-1426.
15. Camerer E, Huang W, Coughlin SR. Tissue factor- and factor X-dependent activation of protease-activated receptor-2 by factor VIIa. Proc Natl Acad Sci USA. 2000;97:5255-5260.
16. Bono F, Schaeffer P, Herault J-P, Michaux C, Nestor A-L, Guillemot J-C, Herbert JM. Factor Xa activates endothelial cells by a receptor cascade between EPR-1 and PAR-2. Arterioscler Thromb Vasc Biol. 2000;20:e107-e112.
17. Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407:258-264.
18. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, Plevin R. Proteinase-activated receptors. Pharmacol Rev. 2001;53:245-282.
19. O'brien PJ, Molino M, Kahn M, Brass LF. Protease activated receptors: theme and variations. Oncogene. 2001;20:1570-1581.
20. Bazan JF. Structural design and molecular evolution of a cytokine receptor super family. Proc Natl Acad Sci USA. 1990;87:6934-6938.
21. Rottingen JA, Enden T, Camerer E, Iversen JG, Prydz H. Binding of human factor VIIa to tissue factor induces cytosolic Ca2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesize tissue factor. J Biol Chem. 1995;270:4650-4660.
22. Camerer E, Rottingen JA, Iversen JG, Prydz H. Coagulation factors VII and X induce Ca2+ oscillations in Madin-Darby canine kidney cells. J Biol Chem. 1996;271:29034-29042.
23. Prydz HS, Camerer E, Rottingen J-A, Wiiger MT, Gjernes E. Cellular consequences of the initiation of blood coagulation. Thromb Haemost. 1999;82:183-192.
24. Camerer E, Rottingen J-A, Gjernes E, Larsen K, Skartlien AH, Iversen J-G, Prydz H. Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem. 1999;274:32225-32233.
25. Poulsen LK, Jacobsen N, Sorensen BB, Bergenhem NCH, Kelly JD, Foster DC, Thastrup O, Ezban M, Petersen LC. Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor. J Biol Chem. 1998;273:6228-6232.
26. Sorensen BB, Freskgard P-O, Nielsen LS, Rao LVM, Ezban M, Petersen LC. Factor VIIa-induced p44/42 mitogen-activated kinase activation requires the proteolytic activity of factor VIIa and is independent of the tissue factor cytoplasmic domain. J Biol Chem. 1999;274:21349-21354.
27. Pendurthi U, Sorensen BB, Petersen LC, Ezban M, Hagel G, Thastrup O, Rao LVM. Factor VIIa induced signaling in flbroblasts. Blood 2000;96:635a.
28. Camerer E, Gjernes E, Wiiger M, Pringle S, Prydz H. Binding of factor VIIa to tissue factor on keratinocytes induces gene expression. J Biol Chem. 2000;275:6580-6585.
29. Versteeg HH, Hoedemaeker I, Diks SH, Stam JC, Spaargaren M, Bergen en Henegouwen PMP, Deventer SJH, Peppelenbosch MP. Factor VIIa/ Tissue factor-induced signaling via activation of Src-like Kinase, Phosphatidylinositol 3-Kinase, and Rac. J Biol Chem. 2000;275:28750-28756.
30. Versteeg HH, Bresser HL, Spek CA, Richel DJ, Deventer SJH. Regulation of the p21 RAS-MAP kinase pathway by factor VIIa. J Thromb Haemost. 2003;1:1012-1018.
31. Wiiger MT, Prydz H. The epidermal growth factor receptor (EGFR) and proline rich tyrosine kinase 2 (PYK2) are involved in tissue factor dependent factor VIIa signalling in HaCaT cells. Thromb Haemost. 2004;92:13-22.
32. Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature. 1995;376:737-745.
33. Versteeg HH, Spek CA, Slofstra SH, Diks SH, Richel DJ, Peppelenbosch MP. FVIIa:TF induces cell survival via G12/G13-dependent Jak/STAT activation and BclXL production. Circ Res. 2004;94:1032-1040.
34. Versteeg HH, Sorensen BB, Slofstra S, Van den Brande JHM, Stam JC, van Bergen en Henegouwen PMP, Richel DJ, Petersen LC, Peppelenbosch MP. VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation. J Biol Chem. 2002;277:27065-27072.
35. Ollivier V, Bentolila S, Chabbat J, Hakim J, de Prost D. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Blood. 1998;91:2698-2703.
36. Taniguchi T, Kakkar AK, Tuddenham EGD, Williamson RCN, Lemoine NRL. Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer. Cancer Res. 1998;58:4461-4467.
37. Wang X, Gjernes E, Prydz H. Factor VIIa induces tissue factor-dependent up-regulation of interleukin-8 in a human keratinocyte line. J Biol Chem. 2002;277:23620-23626.
38. Hjortoe GM, Petersen LC, Albrektsen T, Sorensen BB, Norby PL, Mandal SK, Pendurthi UR, Rao LV. Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood. 2004;103:3029-3037.
39. Pendurthi UR, Allen KE, Ezban M, Rao LVM. Factor VIIa and thrombin induce the expression of Cyr61 and connective tissue growth factor, extracellular matrix signaling proteins that could act as possible downstream mediators in factor VII. tissue factor-induced signal transduction. J Biol Chem. 2000;275:14632-14641.
40. Lau LF, Lam S. The CCN family of angiogenic regulators: The integrin connection. Exp Cell Res. 1999;248:44-57.
41. Petersen LC, Thastrup O, Hagel G, Sorensen BB, Freskgard P-O, Rao LVM, Ezban M. Exclusion of known protease activated receptors in factor VIIa-induced signal transduction. Thromb Haemost. 2000;83:571-576.
42. Riewald M, Ruf W. Mechanistic coupling of protease signaling and initiation of coagulation by tissue factor. Proc Natl Acad Sci USA. 2001;98:7742-7747.
43. Marutsuka K, Hatakeyama K, Sato Y, Yamashita A, Sumiyoshi A, Asada Y. Protease-activated receptor -2 (PAR2) mediates vascular smooth muscle cell migration induced by tissue factor/factor VIIa complex. Thromb Res. 2002;107:271-276.
44. Ishii K, Hein L, Kobilka B, Coughlin SR. Kinetics of thrombin receptor cleavage on intact cells. Relation to signaling. J Biol Chem. 1993;268:9780-9785.
45. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC. Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood. 1993;81:734-744.
46. Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992;80:25-28.
47. Neuenschwander PF, Fiore MM, Morrissey JH. Factor VII autoactivation proceeds via interaction of distinct protease-cofactor and zymogen-cofactor complexes. J Biol Chem. 1993;268:21489-21492.
48. Yamamoto M, Nakagaki T, Kisiel W. Tissue factor dependent autoactivation of human blood coagulation factor VII. J Biol Chem. 1992;267:19089-19094.
49. Rao LVM, Williams T, Rapaport SI. Studies of the activation of factor VII bound to tissue factor. Blood. 1996;87:3738-3748.
50. Ruf W, Dorfleutner A, Riewald M. Specificity of coagulation factor signaling. J Thromb Haemost. 2003;1:1495-1503.
51. Zioncheck TF, Roy S, Vehar GA. The cytoplasmic domain of tissue factor is phosphorylated by a protein kinase C-dependent mechanism. J Biol Chem. 1992;267:3561-3564.
52. Mody RS, Carson SD. Tissue factor cytoplasmic domain peptide is multiply phosphorylated in vitro. Biochem. 1997;36:7869-7875.
53. Dorfleutner A, Ruf W. Regulation of tissue factor cytoplasmic domain phosphorylation by palmitoylation. Blood. 2003;102:3998-4005.
54. Bromberg ME, Konigsberg WH, Madison JF, Pawashe A, Garen A. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA. 1995;92:8205-8209.
55. Mueller BM, Ruf W. Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis. J Clin Invest. 1998;101:1372-1378.
56. Bromberg ME, Sundaram R, Homer RJ, Garen A, Konigsberg WH. Role of tissue factor in metastasis: Functions of the cytoplasmic and extracellular domains of the molecule. Thromb Haemost. 1999;82:88-92.
57. Abe K, Shoji M, Chen J, Bierhaus A, Danave I, Micko C, Casper K, Dillehay DL, Nawroth P, Rickles FR. Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA. 1999;96:8663-8668.
58. Bromberg ME, Garen A, McNiff J, Konigsberg WH. Overexpression of tissue factor does not promote metastasis by upregulation of VEGF or angiogenesis in melanoma cells. Blood 1997;90(suppl):293a.
59. Ahamed J, Ruf W. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain. J Biol Chem. 2004;279:23038-23044.
60. Belting M, Dorrell MI, Sandgren S, Aguilar E, Ahamed J, Dorfleutner A, Carmeliet P, Mueller BM, Friedlander M, Ruf W. Regulation of angiogenesis by tissue factor cytoplasmic domain signaling. Nat Med. 2004;10:502-509.
61. Taylor FB, Chang A, Ruf W, Morrissey JH, Hinshaw LB, Catlett R, Blick K, Edgington TS. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock. 1991;33:127-134.
62. Creasey AA, Chang ACK, Feigen L, Wun TC, Taylor FB, Hinshaw LB. Tissue factor pathway inhibitor reduces mortality from E. coli septic shock. J Clin Invest. 1993;91:2850-2860.
63. Taylor FB, Chang ACK, Peer G, Li A, Ezban M, Hedner U. Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8 but not tumor necrosis factor responses of the baboon to LD 100 E. coli. Blood. 1998;91:1609-1615.
64. Taylor FB, Chang ACK, Peer GT, Mather T, Blick K, Catlett R, Lockhart M, Esmon CT. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by E. Coli without preventing shock or organ damage. Blood. 1991;78:364-368.
65. Randolph MM, White GL, Kosanke SD, Bild G, Carr C, Galluppi G, Hinshaw LB, Taylor FB, Jr. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli-a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli. Thromb Haemost. 1998;79:1048-1053.
66. Miller DL, Welty-wolf KE, Carraway MS, Ezban M, Ghio A, Suliman H, Piantadosi CA. Extrinsic coagulation cascade blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide. Am J Respir Cell Mol Biol. 2002;26:650-658.
67. Randolph GJ, Luther T, Albrecht S, Magdolen V, Muller WA. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood. 1998;92:4167-4177.
68. Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG. Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood. 1999;94:3413-3420.
69. Pawlinski R, Pedersen B, Schabbauer G, Tencati M, Holscher T, Boisvert W, Andrade-Gordon P, Frank RD, Mackman N. Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia. Blood. 2004;103:1342-1347.
70. Sharma L, Melis E, Hickey MJ, Clyne CD, Erlich J, Khachigian LM, Davenport P, Morand E, Carmeliet P, Tipping PG. The cytoplasmic domain of tissue factor contributes to leukocyte recruitment and death in endotoxemia. Am J Pathol. 2004;165:331-340.
71. Browder T, Folkman J, Pine-Shepherd S. The hemostatic system as a regulator of angiogenesis. J Biol Chem. 2000;275:1521-1524.
72. Zhang Y, Deng Y, Luther T, Muller M, Ziegler R, Waldherr R, Stern DM, Nawroth P. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 1994;94:1320-1327.
73. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol. 2003;170:3369-3376.
74. 3. J Biol Chem. 1998;273:3090-3096.
75. Planque N, Perbal B. A structural approach to the role of CCN (CYR61/ CTGF/NOV) proteins in tumourigenesis. Cancer Cell Int. 2003;3:15.
76. Dorfleutner A, Hintermann E, Tarui T, Takada Y, Ruf W. Crosstalk of Integrin {alpha}3{beta}1 and Tissue Factor in Cell Migration. Mol Biol Cell. 2004;15:4416-4425.
77. Ott I, Fischer EG, Miyagi Y, Mueller BM, Ruf W. A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J Cell Biol. 1998;140:1241-1253.
78. Rao LVM. Tissue factor as a tumor procoagulant. Cancer Metastasis Rev. 1992;11:249-266.
79. Hamada K, Kuratsu J, Saitoh Y, Nishi T, Ushio Y. Expression of tissue factor expression correlates with grade of malignancy in human glioma. Cancer. 1996;77:1877-1883.
80. Kakkar AK, Lemoine NR, Scully MF, Tebbutt S, Williamson RC. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg. 1995;82:1101-1104.
81. Shigemori C, Wada H, Matsumoto K, Shiku H, Nakamura S, Suzuki H. Tissue factor expression and metastatic potential of colorectal cancer. Thromb Haemost. 1998;80:894-898.
82. Seto S, Onodera H, Kaido T, Yoshikawa A, Ishigami S, Arii S, Imamura M. Tissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosis. Cancer. 2000;88:295-301.
83. Mueller BM, Reisfeld RA, Edgington TS, Ruf W. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis. Proc Natl Acad Sci USA. 1992;89:11832-11836.
84. Dimmeler S, Zeiher AM. Endothelial cell apoptosis in angiogenesis and vessel regression. Circ Res. 2000;87:434-439.
85. Bergmann A, Agapite J, McCall K, Steller H. The Drosophila gene hid is a direct molecular target of Ras-dependent survival signaling. Cell. 1998;95:331-341.
86. Yu J, Zhang L. Apoptosis in human cancer cells. Curr Opin Oncol. 2004;16:19-24.
87. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. 2004;53:153-159.
88. Versteeg HH, Spek CA, Richel DJ, Peppelenbosch MP. Coagulation factors VIIa and Xa inhibit apoptosis and anoikis. Oncog. 2004;23:410-417.
89. Sorensen BB, Rao LVM, Tornehave D, Gammeltoft S, Petersen LC. Antiapoptotic effect of coagulation factor VIIa. Blood. 2003;102:1708-1715.
90. D'Andrea MR, Derian CK, Santulli RJ, Andrade-Gordon P. Differential expression of protease-activated receptors-1 and -2 in stromal fibroblasts of normal, benign, and malignant human tissues. Am J Pathol. 2001;158:2031-2041.
91. Even-ram SC, Uziely B, Cohen P, Grisaru-granovsky S, Reich R, Bar-Shavit R, Giocondi M. Thrombin receptor overexpression in malignant and physiological invasion processes. Nat Med. 1998;4:909-914.
92. Fischer EG, Ruf W, Mueller BM. Tissue factor-initiated thrombin generation activates the signalling thrombin receptor on malignant melanoma cells. Cancer Res. 1995;55:1629-1632.
93. Tellez C, Bar-Eli M. Role and regulation of the thrombin receptor (PAR-1) in human melanoma. Oncogene. 2003;22:3130-3137.
94. Nierodzik ML, Chen K, Takeshita K, Li JJ, Huang YQ, Feng XS, D'Andrea MR, Andrade-Gordon P, Karpatkin S. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood. 1998;92:3694-3700.
95. Bromberg ME, Bailly MA, Konigsberg WH. Role of protease-activated receptor 1 in tumor metastasis promoted by tissue factor. Thromb Haemost. 2001;86:1210-1214.
96. 5 integrin. J Biol Chem. 2001;276:10952-10956.
97. Darmoul D, Gratio V, Devaud H, Lehy T, Laburthe M. Aberrant expression and activation of the thrombin receptor protease-activated receptor-1 induces cell proliferation and motility in human colon cancer cells. Am J Pathol. 2003;162:1503-1513.
98. Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM. Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res. 2004;2:395-402.
99. Camerer E, Qazi AA, Duong DN, Cornelissen I, Advincula R, Coughlin SR. Platelets, protease-activated receptors, and fibrinogen in hematogenous metastasis. Blood. 2004;104:397-401.
100. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev. 2003;83:835-870.
101. Martin P. Wound healing-aiming for perfect skin regeneration. Science. 1997;276:75-81.
102. Chen C-C, Mo F-E, Lau LF. The angiogenic factor Cyr61 activates a genetic program for wound healing in human skin fibroblasts. J Biol Chem. 2001;276:47329-47334.
103. Wang JF, Olson ME, Ball DK, Brigstock DR, Hart DA. Recombinant connective tissue growth factor modulates porcine skin fibroblast gene expression. Wound Repair Regen. 2003;11:220-229.
104. Ardissino D, Merlini PA, Arlens R, Coppola R, Bramucci E, Lucreziotti S, Repetto A, Fetiveau R, Mannucci PM. Tissue factor in human coronary atherosclerotic plaques. Clinica Chimica Acta. 2000;291:235-240.
105. Ardissino D, Merlini PA, Bauer KA, Bramucci E, Ferrario M, Coppola R, Fetiveau R, Lucreziotti S, Rosenberg RD, Mannucci PM. Thrombogenic potential of human coronary atherosclerotic plaques. Blood. 2001;98:2726-2729.
106. Marmur JD, Thiruvikraman SV, Fyfe BS, Guha A, Sharma SK, Ambrose JA, Fallon JT, Nemerson Y, Taubman MB. Identification of active tissue factor in human coronary atheroma. Circulation. 1996;94:1226-1232.
107. Taubman MB, Fallon JT, Scheeler AD, Giesen P, Mendlowitz M, Fyfe BS, Marmur JD, Nemerson Y. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost. 1997;78:200-204.
108. Sato Y, Asada Y, Marutsuka K, Hatakeyama K. Tissue factor induces migration of cultured aortic smooth muscle cells. Thromb Haemost. 1996;75:389-392.
109. Sato Y, Kataoka H, Asada Y, Marutsuka K, Kamikubo YI, Koono M, Sumiyoshi A. Overexprssion of tissue factor pathway inhibitor in aortic smooth muscle cells inhibits cell migration induced by tissue factor/ factor VIIa complex. Thrombosis Res. 1999;94:401-406.
110. Singh R, Pan S, Mueske CS, Witt T, Kleppe LS, Peterson TE, Slobodova A, Chang J-Y, Caplice NM, Simari RD. Role for tissue factor pathway in murine model of vascular remodeling. Circ Res. 2001;89:71-76.
111. Siegbahn A, Johnell M, Rorsman C, Ezban M, Heldin C-H, Ronnstrand L. Binding of factor VIIa to tissue factor on human fibroblasts leads to activation of phospholipase C and enhanced PDGF-BB-stimulated chemotaxis. Blood. 2000;96:3452-3458.
112. Cirillo P, Cali O, Golino P, Calabro P, Forte L, De Rosa S, Pacileo M, Ragni M, Scopacasa F, Nitsch L, Chiariello M. Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation. 2004;109:2911-2916.
113. Mandal SK, Rao LVM, Tran TT, Pendurthi UR. A novel mechanism of plasmin-induced mitogenesis in fibroblasts. J Thromb Haemost 2004. In press.
114. Herbert JM, de Prost D, Ollivier V, Melis E, Carmeliet P. Tissue factor is not involved in the mitogenic activity of factor VIIa. Biochem Biophys Res Commun. 2001;281:1074-1077.
115. Oemar BS, Werner A, Garnier JM, Do DD, Godoy N, Nauck M, Marz W, Rupp J, Pech M, Luscher TF. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation. 1997;95:831-839.
116. Oemar BS, Luscher TF. Connective tissue growth factor: Friend or foe? Arterioscler Thromb Vasc Biol. 1997;17:1483-1489.
117. Schober JM, Chen N, Grzeszkiewicz TM, Jovanovic I, Emeson EE, Ugarova TP, Ye RD, Lau LF, Lam SC. Identification of integrin alpha-(M)beta(2) as an adhesion receptor on peripheral blood monocytes for Cyr61 (CCN1) and connective tissue growth factor (CCN2): immediate-early gene products expressed in atherosclerotic lesions. Blood. 2002;99:4457-4465.
118. Hilfiker A, Hilfiker-Kleiner D, Fuchs M, Kaminski K, Lichtenberg A, Rothkotter HJ, Schleifer B, Drexler H. Expression of CYR61, an angiogenic immediate early gene, in arteriosclerosis and its regulation by angiotensin II. Circulation. 2002;106:254-260.
119. Wilcox JN, Noguchi S, Casanova J. Extrahepatic synthesis of factor VII in human atherosclerotic vessels. Arterioscler Thromb Vasc Biol. 2003;23:136-141.
120. 3. J Biol Chem. 1999;274:24321-24327.